MedPath

Comparative Analysis of Large Macular Hole Surgeries

Not Applicable
Conditions
Macular Holes
Interventions
Procedure: the Cover group
Procedure: the peeling group
Procedure: the Fill group
Registration Number
NCT04116892
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brief Summary

This study compares the anatomical and visual outcomes in a large series of patients affected by idiopathic macular holes larger than 400 µm treated using pars plana vitrectomy and gas tamponade combined with internal limiting membrane (ILM) peeling or the inverted internal limiting membrane flap technique. A part of the participants will receive internal limiting membrane peeling,whil the other will receive the inverted internal limiting membrane flap technique.

Detailed Description

Vitrectomy is the standard treatment for idiopathic macular holes (IMHs) and is combined with removal of the internal limiting membrane (ILM) to improve anatomical outcomes.However, surgical closure is not achieved after a single operation in all cases, and patients with long-standing MHs or highly myopic eyes are challenging to treat.Various surgical strategies have been introduced to improve postoperative outcomes for these cases. Michalewska et al. have reported an inverted ILM flap technique for large MHs. The ILM around the MH was left to cover or fill the hole and showed a better anatomical closure rate and visual outcome than ILM peeling for large MHs. Nevertheless, the functional and anatomic outcomes of the ILM flap technique have not been investigated as extensively as the ILM peeling technique and have yet to be confirmed by research comparing the ILM flap technique with the conventional procedure.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • idiopathic MHs, a minimum hole diameter of ≥ 400 μm, and follow-up for at least 3 months after vitrectomy.
Exclusion Criteria
  • High myopia (≥6 diopters,AL≥26.5mm), increased intraocular pressure (IOP, >21 mm Hg) or glaucoma, severe cataract, severe systemic conditions that prevent surgery, and history of ocular trauma, intraocular inflammation, retinal vascular disease, or previous ocular surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
the Cover groupthe Cover groupthe internal limiting membrane was peeled centripetally all the way up to the MH rim and the hinged ILM flap folded upside-down on top of the MH in order to bridge the entire retinal defect with a single layer.
the peeling groupthe peeling groupthe internal limiting membrane was discarded
the Fill groupthe Fill groupthe internal limiting membrane was folded in multiple layers and deliberately "stuffed" or "packed" within the MH defect using a forceps.
Primary Outcome Measures
NameTimeMethod
MH statusat 3 months after surgery

MH status (open, flat open or closed)

IS/OS line interruption widthat 3 months after surgery

IS/OS line interruption width were gauged with spectral-domain optical coherence tomography

Change from Baseline IS/OS line interruption width at 3 monthsat 3 months after surgery

IS/OS line interruption width were gauged with spectral-domain optical coherence tomography

Baseline best-corrected visual acuityat 3 months after surgery

best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis

Change from Baseline best-corrected visual acuity at 3 monthsat 3 months after surgery

best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis

visual functionat 3 months after surgery

visual function were gauged with national eye institute visual function questionnaire-25((NEI VFQ-25)

Change from Baseline visual function at 3 monthsat 3 months after surgery

visual function were gauged with national eye institute visual function questionnaire-25((NEI VFQ-25)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Ophthalmology, The Second Affiliated Hospital, Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath